Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 3 years ago

Possible Interaction: Arachidonic Acid and Meclofenamate

Research Papers that Mention the Interaction

Meclofenamate successfully blocked the conversion of arachidonic acid to vasoconstrictive eicosanoids such as TxA(2); nevertheless, meclofenamate failed to inhibit PH in response to LPS.
Poultry science  •  2009  |  View Paper
In ex vivo assays, meclofenamate , but not nimesulide, prevented the platelet aggregation elicited by arachidonic acid.
Hypertension  •  2000  |  View Paper
The cyclooxygenase inhibitor meclofenamate (3 x 10(-5) M superfusate concentration) completely abolished the dilator responses to topically applied arachidonic acid , but had no effect on the magnitude or rate of sympathetic constriction in any vessel type.
International journal of microcirculation, clinical and experimental  •  1997  |  View Paper
Vasodilator responses to pentoxifylline and acetylcholine were not significantly changed in the presence of meclofenamate, whereas meclofenamate markedly reduced the vasopressor effects of arachidonic acid.
Critical care medicine  •  1996  |  View Paper
Meclofenamate abolished both dilator and constrictor actions of arachidonic acid ; it raised baseline, normoxic pulmonary artery pressure, in chronically hypoxic but not control rats, which suggests that dilator products of arachidonic acid are released in the pulmonary hypertension of chronic hypoxia and attenuate pulmonary artery pressure.
The European respiratory journal  •  1993  |  View Paper
Meclofenamate (10(-5) M) blocked the increased metabolite synthesis over the entire dose range of arachidonic acid tested (7.5 ng-75 micrograms).
Journal of applied physiology  •  1990  |  View Paper
However, the cyclooxygenase inhibitor indomethacin (or meclofenamate ), which completely blocked the dilator response to arachidonic acid but did not change the response to acetylcholine, inhibited the arteriolar dilation (mean increase, 0.3 +/- 0.2 micron) due to increases in red blood cell velocity (9.3 +/- 1.0 mm/sec).
Circulation research  •  1990  |  View Paper
2 Inhibition of cyclo‐oxygenase with indomethacin or meclofenamate reduced the renal vasoconstrictor effect of arachidonic acid.
British journal of pharmacology  •  1989  |  View Paper
Cyclo-oxygenase was inhibited by infusion of meclofenamate (60 micrograms X min-1) which consistently abolished the vasodilator responses to arachidonic acid added to the donor.
Prostaglandins  •  1986  |  View Paper
The vasodilatory effect of arachidonic acid but not acetylcholine was blocked by meclofenamate.
The American journal of physiology  •  1985  |  View Paper
Show More